Format
Sort by

Send to

Choose Destination

Search results

Items: 17

1.

Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).

Scheffer HJ, Vroomen LG, Nielsen K, van Tilborg AA, Comans EF, van Kuijk C, van der Meijs BB, van den Bergh J, van den Tol PM, Meijerink MR.

BMC Cancer. 2015 Oct 24;15:772. doi: 10.1186/s12885-015-1736-5.

2.

Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.

Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.

PLoS One. 2015 Aug 13;10(8):e0135773. doi: 10.1371/journal.pone.0135773. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137480.

3.

Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.

Schoellhammer HF, Goldner B, Merchant SJ, Kessler J, Fong Y, Gagandeep S.

BMC Cancer. 2015 Apr 12;15:271. doi: 10.1186/s12885-015-1279-9.

4.

Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation.

Martin RC, Philips P, Ellis S, Hayes D, Bagla S.

BMC Cancer. 2014 Jul 26;14:540. doi: 10.1186/1471-2407-14-540.

5.

MR imaging enables measurement of therapeutic nanoparticle uptake in rat N1-S1 liver tumors after nanoablation.

McDevitt JL, Mouli SK, Tyler PD, Li W, Nicolai J, Procissi D, Ragin AB, Wang YA, Lewandowski RJ, Salem R, Larson AC, Omary RA.

J Vasc Interv Radiol. 2014 Aug;25(8):1288-94. doi: 10.1016/j.jvir.2014.03.033. Epub 2014 May 20.

6.

Systematic review of novel ablative methods in locally advanced pancreatic cancer.

Keane MG, Bramis K, Pereira SP, Fusai GK.

World J Gastroenterol. 2014 Mar 7;20(9):2267-78. doi: 10.3748/wjg.v20.i9.2267. Review.

7.

Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA, Larson AC.

Radiology. 2014 Jun;271(3):721-9. doi: 10.1148/radiol.14130989. Epub 2014 Feb 18.

8.

Re: irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Pua U.

Korean J Radiol. 2014 Jan-Feb;15(1):181. doi: 10.3348/kjr.2014.15.1.181. Epub 2014 Jan 8. No abstract available.

9.

Tumor ablation: common modalities and general practices.

Knavel EM, Brace CL.

Tech Vasc Interv Radiol. 2013 Dec;16(4):192-200. doi: 10.1053/j.tvir.2013.08.002. Review.

10.

Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated.

Philips P, Hays D, Martin RC.

PLoS One. 2013 Nov 1;8(11):e76260. doi: 10.1371/journal.pone.0076260. eCollection 2013.

11.

Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Niessen C, Jung EM, Wohlgemuth WA, Trabold B, Haimerl M, Schreyer A, Stroszczynski C, Wiggermann P.

Korean J Radiol. 2013 Sep-Oct;14(5):797-800. doi: 10.3348/kjr.2013.14.5.797. Epub 2013 Aug 30.

12.

Irreversible electroporation facilitates gene transfer of a GM-CSF plasmid with a local and systemic response.

Au JT, Mittra A, Song TJ, Cavnar M, Jun K, Carson J, Gholami S, Haddad D, Gaujoux S, Monette S, Ezell P, Wolchok J, Fong Y.

Surgery. 2013 Sep;154(3):496-503. doi: 10.1016/j.surg.2013.06.005.

13.

Cancer concepts and principles: primer for the interventional oncologist-part II.

Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA Jr, Vogelzang RL, Lewandowski RJ, Salem R.

J Vasc Interv Radiol. 2013 Aug;24(8):1167-88. doi: 10.1016/j.jvir.2013.04.023. Epub 2013 Jun 28. Review.

14.

Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.

Ryan ER, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, Thornton R, Siegelbaum RH, Erinjeri JP, Solomon SB.

Radiology. 2013 Jul;268(1):288-95. doi: 10.1148/radiol.13121462. Epub 2013 Apr 5.

15.

Modeling of electric field distribution in tissues during electroporation.

Corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D.

Biomed Eng Online. 2013 Feb 21;12:16. doi: 10.1186/1475-925X-12-16.

16.

Irreversible electroporation is a surgical ablation technique that enhances gene transfer.

Au JT, Wong J, Mittra A, Carpenter S, Haddad D, Carson J, Jayaraman S, Monette S, Solomon SB, Ezell P, Fong Y.

Surgery. 2011 Sep;150(3):474-9. doi: 10.1016/j.surg.2011.07.007.

17.

Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.

Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC.

Cancer Res. 2010 Feb 15;70(4):1555-63. doi: 10.1158/0008-5472.CAN-09-3067. Epub 2010 Feb 2.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk